Nirrin Technologies is introducing a new near-infrared spectroscopy platform utilizing pure-component analysis, which bypasses the costly and time-consuming model-building traditionally required for data interpretation. This development is significant for biotech and pharma companies as it promises to reduce expenses associated with process monitoring, eliminate reliance on external labs, and accelerate analysis speeds for protein characterization. Expect to see increased adoption of this technology initially in process development, with a gradual expansion into commercial manufacturing environments.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
